Shed Membrane Fragment-Associated Markers for Endometrial and Ovarian Cancers
- 31 March 2002
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 84 (3), 443-448
- https://doi.org/10.1006/gyno.2001.6551
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- CD95 ligand expression as a mechanism of immune escape in breast cancerImmunology, 2000
- Sonographic endometrial thickness: a useful test to predict atrophy in patients with postmenopausal bleeding. An Italian multicenter studyUltrasound in Obstetrics & Gynecology, 1996
- Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover.The Journal of cell biology, 1996
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- A role for CD95 ligand in preventing graft rejectionNature, 1995
- Fas-mediated cytotoxicity by freshly isolated natural killer cells.The Journal of Experimental Medicine, 1995
- Characterization of plasma membrane shedding from murine melanoma cellsInternational Journal of Cancer, 1988
- Enzyme-linked coagulation assayAnalytical Biochemistry, 1987
- Isolation of plasma membrane fragments from cultured murine melanoma cellsBiochemical and Biophysical Research Communications, 1983
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970